We are live on
!
Find out more
ProShare Advisors Portfolio holdings
AUM
$67.5B
1-Year Est. Return
28.09%
This Quarter
Est. Return
+9.51%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$28.5B
AUM Growth
+$2.42B
(+9.3%)
Cap. Flow
+$581M
Cap. Flow
% of AUM
2.04%
Top 10 Holdings %
Top 10 Hldgs %
19.66%
Holding
1,921
New
171
Increased
1,320
Reduced
356
Closed
71
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$111M |
| 2 |
VF Corp
VFC
|
+$73.4M |
| 3 |
Amazon
AMZN
|
+$71M |
| 4 |
Stanley Black & Decker
SWK
|
+$60.2M |
| 5 |
Tesla
TSLA
|
+$46.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Target
TGT
|
+$158M |
| 2 |
Apple
AAPL
|
+$130M |
| 3 |
Cardinal Health
CAH
|
+$43.7M |
| 4 |
Fortinet
FTNT
|
+$39.6M |
| 5 |
ExxonMobil
XOM
|
+$32.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.73% |
| 2 | Industrials | 12.07% |
| 3 | Consumer Staples | 11.64% |
| 4 | Healthcare | 11.12% |
| 5 | Financials | 10.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1676
MacroGenics
MGNX
$235M
| $86.2K | ﹤0.01% |
12,841
+1,026
| +9% | +$5.63K |
|
|
BLU
1677
DELISTED
BELLUS Health Inc.
BLU
| $85.5K | ﹤0.01% |
10,404
-179
| -2% | -$1.67K |
|
|
VRAY
1678
DELISTED
ViewRay, Inc.
VRAY
| $85.3K | ﹤0.01% |
19,051
+2,729
| +17% | +$11.9K |
|
1679
Community Health Systems
CYH
$385M
| $85.3K | ﹤0.01% |
19,745
+2,548
| +15% | +$7.84K |
|
1680
SiriusPoint
SPNT
$2.98B
| $84.6K | ﹤0.01% |
14,332
+1,861
| +15% | +$10.9K |
|
|
LICY
1681
DELISTED
Li-Cycle Holdings Corp.
LICY
| $83.7K | ﹤0.01% |
2,198
+315
| +17% | +$14.1K |
|
1682
American Well
AMWL
$181M
| $83.5K | ﹤0.01% |
1,476
+212
| +17% | +$15.3K |
|
1683
GoPro
GPRO
$116M
| $82.8K | ﹤0.01% |
16,629
+2,382
| +17% | +$12.5K |
|
1684
Compass
COMP
$8.27B
| $81.9K | ﹤0.01% |
35,144
+5,036
| +17% | +$13.2K |
|
1685
Inovio Pharmaceuticals
INO
$79.8M
| $81.8K | ﹤0.01% |
4,370
+351
| +9% | +$7.96K |
|
1686
Cerus
CERS
$587M
| $81.1K | ﹤0.01% |
22,206
+3,183
| +17% | +$12K |
|
1687
Nordic American Tanker
NAT
$1.37B
| $80.8K | ﹤0.01% |
26,415
+4,557
| +21% | +$14.7K |
|
|
LGF.B
1688
DELISTED
Lions Gate Entertainment Corp. Class B Non-Voting Shares
LGF.B
| $80.7K | ﹤0.01% |
14,860
+2,130
| +17% | +$14.1K |
|
1689
Atea Pharmaceuticals
AVIR
$379M
| $80.4K | ﹤0.01% |
16,707
+1,291
| +8% | +$6.53K |
|
|
PNT
1690
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
| $80.2K | ﹤0.01% |
+10,999
| New | +$81.6K |
|
1691
Erasca
ERAS
$6.63B
| $79.6K | ﹤0.01% |
18,466
+1,041
| +6% | +$7.06K |
|
|
SCS
1692
DELISTED
Steelcase
SCS
| $79.2K | ﹤0.01% |
+11,200
| New | +$82.8K |
|
1693
Enviri
NVRI
$621M
| $78.2K | ﹤0.01% |
12,425
+1,603
| +15% | +$9.55K |
|
|
CTIC
1694
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
| $77.4K | ﹤0.01% |
12,885
+1,847
| +17% | +$10.1K |
|
1695
Caribou Biosciences
CRBU
$156M
| $77K | ﹤0.01% |
12,263
+963
| +9% | +$8.57K |
|
1696
indie Semiconductor
INDI
$733M
| $76.5K | ﹤0.01% |
13,129
+1,882
| +17% | +$13.9K |
|
1697
8x8 Inc
EGHT
$247M
| $75.9K | ﹤0.01% |
17,577
+1,138
| +7% | +$4.57K |
|
|
BRSP
1698
BrightSpire Capital
BRSP
$681M
| $75.1K | ﹤0.01% |
12,059
+1,729
| +17% | +$12K |
|
1699
DocGo
DCGO
$58.9M
| $75.1K | ﹤0.01% |
+10,617
| New | +$89.1K |
|
1700
Opendoor
OPEN
$3.7B
| $75K | ﹤0.01% |
66,787
+3,659
| +6% | +$7.02K |
|
Similar funds
ProShare Advisors's Q4 2022 Portfolio in Review
As of Q4 2022, ProShare Advisors held 1,921 positions worth $28.5B, up 9.3% from $26.1B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
ProShare Advisors's Q4 2022 filing shows 171 new, 1,320 increased, 356 reduced and 71 closed positions. Its largest new stake was Rivian: 689,839 shares worth $12.7M. The largest sale was Target, an estimated $158M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 24% a quarter earlier, followed by Industrials and Consumer Staples.
- ProShare Advisors's largest Q4 2022 buy was Rivian: 689,839 shares worth $12.7M.
- ProShare Advisors added most to Microsoft in Q4 2022, an estimated $111M increase.
- ProShare Advisors's biggest Q4 2022 reduction was Apple, cutting an estimated $130M.
- ProShare Advisors fully exited Target in Q4 2022, selling an estimated $158M.
- ProShare Advisors's ten largest holdings make up 20% of its $28.5B portfolio in Q4 2022.
- ProShare Advisors opened 171 new positions and closed 71 in Q4 2022.
- ProShare Advisors's portfolio value rose 9.3% quarter-over-quarter to $28.5B.
Based on ProShare Advisors's 13F filing for Q4 2022, filed 2 Feb 2023.